6
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      TinderMIX: Time-dose integrated modelling of toxicogenomics data

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Omics technologies have been widely applied in toxicology studies to investigate the effects of different substances on exposed biological systems. A classical toxicogenomic study consists in testing the effects of a compound at different dose levels and different time points. The main challenge consists in identifying the gene alteration patterns that are correlated to doses and time points. The majority of existing methods for toxicogenomics data analysis allow the study of the molecular alteration after the exposure (or treatment) at each time point individually. However, this kind of analysis cannot identify dynamic (time-dependent) events of dose responsiveness.

          Results

          We propose TinderMIX, an approach that simultaneously models the effects of time and dose on the transcriptome to investigate the course of molecular alterations exerted in response to the exposure. Starting from gene log fold-change, TinderMIX fits different integrated time and dose models to each gene, selects the optimal one, and computes its time and dose effect map; then a user-selected threshold is applied to identify the responsive area on each map and verify whether the gene shows a dynamic (time-dependent) and dose-dependent response; eventually, responsive genes are labelled according to the integrated time and dose point of departure.

          Conclusions

          To showcase the TinderMIX method, we analysed 2 drugs from the Open TG-GATEs dataset, namely, cyclosporin A and thioacetamide. We first identified the dynamic dose-dependent mechanism of action of each drug and compared them. Our analysis highlights that different time- and dose-integrated point of departure recapitulates the toxicity potential of the compounds as well as their dynamic dose-dependent mechanism of action.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          Summaries of Affymetrix GeneChip probe level data.

          High density oligonucleotide array technology is widely used in many areas of biomedical research for quantitative and highly parallel measurements of gene expression. Affymetrix GeneChip arrays are the most popular. In this technology each gene is typically represented by a set of 11-20 pairs of probes. In order to obtain expression measures it is necessary to summarize the probe level data. Using two extensive spike-in studies and a dilution study, we developed a set of tools for assessing the effectiveness of expression measures. We found that the performance of the current version of the default expression measure provided by Affymetrix Microarray Suite can be significantly improved by the use of probe level summaries derived from empirically motivated statistical models. In particular, improvements in the ability to detect differentially expressed genes are demonstrated.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The Comparative Toxicogenomics Database: update 2017

            The Comparative Toxicogenomics Database (CTD; http://ctdbase.org/) provides information about interactions between chemicals and gene products, and their relationships to diseases. Core CTD content (chemical-gene, chemical-disease and gene-disease interactions manually curated from the literature) are integrated with each other as well as with select external datasets to generate expanded networks and predict novel associations. Today, core CTD includes more than 30.5 million toxicogenomic connections relating chemicals/drugs, genes/proteins, diseases, taxa, Gene Ontology (GO) annotations, pathways, and gene interaction modules. In this update, we report a 33% increase in our core data content since 2015, describe our new exposure module (that harmonizes exposure science information with core toxicogenomic data) and introduce a novel dataset of GO-disease inferences (that identify common molecular underpinnings for seemingly unrelated pathologies). These advancements centralize and contextualize real-world chemical exposures with molecular pathways to help scientists generate testable hypotheses in an effort to understand the etiology and mechanisms underlying environmentally influenced diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mechanisms of action of cyclosporine.

              Cyclosporine (cyclosporin A, CsA) has potent immunosuppressive properties, reflecting its ability to block the transcription of cytokine genes in activated T cells. It is well established that CsA through formation of a complex with cyclophilin inhibits the phosphatase activity of calcineurin, which regulates nuclear translocation and subsequent activation of NFAT transcription factors. In addition to the calcineurin/NFAT pathway, recent studies indicate that CsA also blocks the activation of JNK and p38 signaling pathways triggered by antigen recognition, making CsA a highly specific inhibitor of T cell activation. Here we discuss the action of CsA on JNK and p38 activation pathways. We also argue the potential of CsA and its natural counterparts as pharmacological probes.
                Bookmark

                Author and article information

                Journal
                Gigascience
                Gigascience
                gigascience
                GigaScience
                Oxford University Press
                2047-217X
                25 May 2020
                May 2020
                25 May 2020
                : 9
                : 5
                : giaa055
                Affiliations
                [1 ] Faculty of Medicine and Health Technology, Tampere University , Arvo Ylpön katu 34, 33520, Tampere, Finland
                [2 ] BioMediTech Institute, Tampere University , Arvo Ylpön katu 34, 33520, Tampere, Finland
                [3 ] Institute of Biotechnology, University of Helsinki , Viikinkaari 5, 00014, Helsinki, Finland
                Author notes
                Correspondence address. Dario Greco, Arvo Ylpön katu 34, Tampere 33520, Finland. dario.greco@ 123456tuni.fi
                Author information
                http://orcid.org/0000-0001-9195-9003
                Article
                giaa055
                10.1093/gigascience/giaa055
                7247400
                32449777
                79c7ac21-b53c-49b2-bf66-1701f6168f15
                © The Author(s) 2020. Published by Oxford University Press.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 27 February 2020
                : 22 April 2020
                : 05 May 2020
                Page count
                Pages: 11
                Funding
                Funded by: Academy of Finland, DOI 10.13039/501100002341;
                Award ID: 322761
                Categories
                Research
                AcademicSubjects/SCI00960
                AcademicSubjects/SCI02254

                toxicogenomics,gene expression,integrated modeling,dose-response,time course,bmd,dynamic dose-dependent,mechanism of action,moa

                Comments

                Comment on this article